As the number of talcum powder cancer lawsuits against Johnson & Johnson continue to mount, plaintiffs have indicated that they support a request filed by the company to centralize the litigation. All plaintiffs cite similar allegations that use of the manufacturer’s Baby Power and Shower-to-Shower body powder products around the... Read more »

A leading professional organization devoted to the care and treatment of diabetes patients has announced a conference convened to review ketoacidosis as one of a handful of possible SGLT2 inhibitor side effects.   The American Association of Clinical Endocrinologists (AACE) announced plans for the conference on June 29 after receiving questions... Read more »

Defendants named in multiple talc body powder lawsuits have filed a formal request for case centralization. The defendants have asked that the lawsuits filed in New Jersey, which total over 100 with more than 156 plaintiffs, be consolidated into a multicounty litigation (MCL) in the Atlantic County Superior Court before... Read more »

The FDA issued a safety communication on May 15 warning of serious Invokana side effects involving ketoacidosis, a condition in which too much of certain kinds of acid (ketones) are found in the blood. The agency noted that several instances of the condition, resulting in hospitalization or emergency room visits,... Read more »

The controversial blood thinning drug Xarelto has been named in yet another lawsuit – this time, tragically, following the death of an elderly Missouri resident who was prescribed the medication by his treating physician in December, 2012. Xarelto has been targeted with increasing scrutiny over the past several years, and... Read more »

Less than two weeks ago, the FDA released an important drug safety communication regarding a new class of diabetes drugs, including those marketed under the brand names Invokana, Farxiga and Jardiance. Health regulators caution that diabetic patients taking this class of sodium-glucose cotransporter-2 (SGLT2) inhibitors may be at risk for... Read more »

In April, the Colgate-Palmolive Co. was ordered to pay $12.4 million in damages to a woman who filed a talc cancer lawsuit against the company. Judith Winkel and her husband John Winkel of Santa Barbara were awarded the funds after a Los Angeles jury found that an asbestos-contaminated talcum powder... Read more »

A Texas man has filed a Xarelto lawsuit against Janssen Pharmaceuticals, claiming the drug caused him to suffer a number of serious health issues. Anthony L. Romaniello was prescribed Xarelto by his physician for atrial fibrillation on January 5, 2013. He continued to use the drug until approximately April 24,... Read more »

On March 27, 2015, a former Risperdal patient filed a lawsuit in U.S. District Court for the Eastern District of Louisiana against several drug manufacturers, including Janssen Pharmaceuticals and Johnson & Johnson. The complaint is one of several ongoing causes of action against the makers of the powerful antipsychotic drug, which... Read more »

A class action lawsuit brought against baby powder manufacturer Johnson & Johnson has been dismissed by a federal judge, because allegations by the plaintiff did not include any documented injuries. However, many other baby powder cancer lawsuits are currently pending across the country, filed by women who did indeed suffer... Read more »